More News

17 Apr 2007 Regulatory Review Allows LCT Diabetes Clinical Program to Proceed
17 Apr 2007 Metabasis Therapeutics Presents Results of a Clinical Study for Its Novel Liver-Targeted Product Candidate for the Treatment of HCC at American Association for Cancer Research
14 Apr 2007 Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275
14 Apr 2007 Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
13 Apr 2007 MedImmune Explores Strategic Alternatives
13 Apr 2007 Intarcia Therapeutics Announces Final Results From A Phase 2 Study Of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
13 Apr 2007 Coley Pharmaceutical Group Licenses VaxImmune(TM) to Merck for Use in Vaccine Programs
13 Apr 2007 Ranbaxy Receives FDA Approval To Market Loratadine Antihistamine Tablets
13 Apr 2007 Anika Therapeutics Receives CE Mark Approval for its Cosmetic Tissue Augmentation Product ELEVESS(TM) to be Marketed by Galderma
12 Apr 2007 Roche and Transgene enter partnership on therapeutic vaccines against HPV-mediated diseases
12 Apr 2007 Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense Inhibitors From Isis Pharmaceuticals
12 Apr 2007 Xanthus Acquires from Johns Hopkins University Exclusive License to Patent Estate Covering FLT3 Pathway as a Target for Treating Autoimmune Diseases
12 Apr 2007 Repligen Licenses Potential Treatment for Friedreich's Ataxia from The Scripps Research Institute
12 Apr 2007 TopoTarget enters into share purchase agreement for the acquisition of Apoxis SA and plans to raise new capital through an offer of new shares
11 Apr 2007 Pfizer and Renovis Extend Research Collaboration to Identify Small Molecule VR1 Antagonists
11 Apr 2007 Inhibitex Signs Definitive Agreement to Acquire FermaVir Pharmaceuticals
10 Apr 2007 Caliper Life Sciences to Explore Novel Indications for Drug Candidates
07 Apr 2007 Stratagene Signs Definitive Agreement to Be Acquired by Agilent Technologies
06 Apr 2007 JDRF To Collaborate with MediGene to Develop an Antigen-Specific Immunotherapeutic for Type I Diabetes
05 Apr 2007 pSivida signs A$203 million (US$165 million)
05 Apr 2007 pSivida signs A$203 million (US$165 million)
05 Apr 2007 AVEO enters into Worldwide License and Development Agreement with Schering-Plough for AV-299, AVEO's Novel Anti-HGF Antibody
05 Apr 2007 Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
05 Apr 2007 CytoGenix Announces Successful Testing of synDNA(TM) Vaccine for Avian Influenza Virus
05 Apr 2007 Boca Pharmacal Receives FDA Approval for Generic Pamine(R) and Pamine(R) Forte Tablets

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top